Voyager Therapeutics (VYGR) Stock Chart & Stock Price History → Truth about Trump you’ve never heard (From Porter & Company) (Ad) Free VYGR Stock Alerts $8.14 +0.32 (+4.09%) (As of 05/30/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Voyager Therapeutics Stock Price Performance5 Day Performance-1.09%1 Month Performance+4.09%3 Month Performance-2.16%6 Month Performance+12.12%Year-To-Date Performance-3.55%1 Year Performance-28.53% Receive VYGR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Voyager Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyKiss of death from Joe BidenI did not consent. You did not consent. It’s in direct violation of the U.S. Constitution but Biden does not care.I have uncovered a bombshell that changes everything… and threatens everything. VYGR Stock Chart for Friday, May, 31, 2024 VYGR Chart by TradingView Voyager Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/30/2024$7.82$8.14+4.09%$8.19$7.81306,344 shs$442.74 million05/29/2024$8.01$7.82-2.37%$7.91$7.68411,305 shs$425.36 million05/28/2024$8.23$8.01-2.67%$8.35$7.83445,435 shs$435.66 million05/27/2024$8.23$8.23$8.30$8.05296,300 shs$447.63 million05/24/2024$8.10$8.23+1.60%$8.30$8.05296,336 shs$447.63 million05/23/2024$8.30$8.10-2.41%$8.31$8.01503,030 shs$440.56 million Get the Latest News and Ratings for VYGR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Voyager Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/22/2024$8.44$8.30-1.66%$8.56$8.24358,066 shs$451.44 million05/21/2024$8.45$8.44-0.12%$8.58$8.34314,106 shs$459.05 million05/20/2024$8.43$8.45+0.24%$8.56$8.35562,157 shs$459.60 million05/17/2024$8.63$8.43-2.32%$8.67$8.35529,986 shs$458.51 million05/16/2024$8.57$8.63+0.70%$8.77$8.30529,825 shs$469.39 million05/15/2024$8.48$8.57+1.06%$8.72$8.32510,531 shs$466.12 million05/14/2024$8.48$8.48$8.86$8.26567,997 shs$461.21 million05/13/2024$8.44$8.48+0.47%$8.79$8.44390,220 shs$461.23 million05/10/2024$8.44$8.44$8.56$8.25388,900 shs$459.04 million05/09/2024$8.57$8.44-1.52%$8.60$8.36331,288 shs$459.04 million05/08/2024$8.77$8.57-2.28%$8.85$8.50387,526 shs$466.12 million05/07/2024$8.94$8.77-1.90%$9.10$8.75385,708 shs$477 million05/06/2024$8.81$8.94+1.48%$8.99$8.66664,495 shs$486.25 million05/03/2024$8.53$8.81+3.28%$8.92$8.61556,020 shs$479.18 million05/02/2024$8.36$8.53+2.03%$8.65$8.27435,781 shs$463.95 million05/01/2024$7.82$8.36+6.91%$8.55$7.80611,451 shs$454.70 million04/30/2024$7.77$7.82+0.64%$7.86$7.62495,064 shs$425.33 million04/29/2024$7.62$7.77+1.97%$7.93$7.68433,889 shs$421.92 million04/26/2024$7.42$7.62+2.70%$7.71$7.32345,051 shs$413.77 million04/25/2024$7.57$7.42-1.98%$7.52$7.26522,452 shs$402.91 million04/24/2024$7.65$7.57-1.05%$7.66$7.45312,783 shs$411.05 million04/23/2024$7.57$7.65+1.06%$7.78$7.57372,354 shs$415.40 million04/22/2024$7.50$7.57+0.93%$7.70$7.47324,115 shs$411.05 million04/19/2024$7.55$7.50-0.66%$7.66$7.28516,124 shs$407.25 million04/18/2024$7.74$7.55-2.45%$7.88$7.511.01 million shs$409.97 million04/17/2024$7.98$7.74-3.01%$8.00$7.70784,399 shs$420.28 million04/16/2024$8.24$7.98-3.16%$8.39$7.95397,456 shs$433.31 million04/15/2024$8.43$8.24-2.25%$8.45$8.13449,905 shs$447.44 million04/12/2024$8.78$8.43-3.99%$8.84$8.39548,924 shs$457.75 million04/11/2024$8.83$8.78-0.57%$9.02$8.75426,033 shs$476.76 million04/10/2024$9.09$8.83-2.86%$8.97$8.70527,186 shs$479.47 million04/09/2024$9.06$9.09+0.33%$9.24$9.00307,812 shs$493.59 million04/08/2024$9.33$9.06-2.89%$9.41$9.02345,591 shs$491.96 million04/05/2024$9.13$9.33+2.19%$9.34$8.97481,361 shs$506.62 millionNvidia is about to pass Apple (Ad)A small handful of companies are working with Nvidia to help ensure that this pivot is a massive success. We call them Nvidia’s “Silent Partners.”Click here to find out who they are.04/04/2024$9.35$9.13-2.35%$9.66$9.12687,972 shs$495.76 million04/03/2024$9.91$9.35-5.65%$9.72$9.25789,475 shs$507.71 million04/02/2024$10.54$9.91-5.98%$10.31$9.68721,516 shs$538.11 million04/01/2024$9.31$10.54+13.21%$10.66$9.431.40 million shs$572.33 million03/29/2024$9.31$9.31$9.68$9.20629,050 shs$505.53 million03/28/2024$9.56$9.31-2.62%$9.68$9.20628,759 shs$505.53 million03/27/2024$10.02$9.56-4.59%$10.17$9.46729,639 shs$519.11 million03/26/2024$9.26$10.02+8.21%$10.19$9.62880,931 shs$544.10 million03/25/2024$9.01$9.26+2.77%$9.34$8.91661,552 shs$502.82 million03/22/2024$9.40$9.01-4.15%$9.60$9.00482,861 shs$489.24 million03/21/2024$10.35$9.40-9.18%$10.57$9.381.08 million shs$510.43 million03/20/2024$10.06$10.35+2.88%$10.40$9.93863,965 shs$562.01 million03/19/2024$9.09$10.06+10.67%$10.14$9.331.13 million shs$546.26 million03/18/2024$9.28$9.09-2.05%$9.36$9.08764,070 shs$493.59 million03/15/2024$9.13$9.28+1.64%$9.41$9.083.89 million shs$503.90 million03/14/2024$9.14$9.13-0.11%$9.17$8.95461,667 shs$495.76 million03/13/2024$9.09$9.14+0.55%$9.35$8.94534,950 shs$496.30 million03/12/2024$9.06$9.09+0.33%$9.25$8.84669,379 shs$493.59 million03/11/2024$9.37$9.06-3.31%$9.39$8.95590,738 shs$491.96 million03/08/2024$9.44$9.37-0.74%$9.95$9.29499,745 shs$508.79 million03/07/2024$9.23$9.44+2.28%$9.79$9.27530,053 shs$512.60 million03/06/2024$9.10$9.23+1.43%$9.47$9.09351,916 shs$501.19 million03/05/2024$9.64$9.10-5.60%$9.75$8.92646,915 shs$494.13 million03/04/2024$9.44$9.64+2.12%$9.68$9.191.12 million shs$523.45 million03/01/2024$8.32$9.44+13.46%$9.52$8.241.23 million shs$415.27 million02/29/2024$8.97$8.32-7.25%$10.63$8.312.07 million shs$366.00 million Related Companies: Adverum Biotechnologies Stock Price Chart bluebird bio Stock Price Chart CASI Pharmaceuticals Stock Price Chart Sana Biotechnology Stock Price Chart Neumora Therapeutics Stock Price Chart Vir Biotechnology Stock Price Chart Ginkgo Bioworks Stock Price Chart Cullinan Therapeutics Stock Price Chart Tarsus Pharmaceuticals Stock Price Chart 4D Molecular Therapeutics Stock Price Chart Receive VYGR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Voyager Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VYGR) was last updated on 5/31/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarElon Musk’s Final Masterpiece: “X-9840”Paradigm PressBiden Nomination CANCELED?The Freeport SocietyGold Set to EXPLODE!Gold Safe ExchangeUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin ProA once-in-a-century profit opportunity?Digital Mavericks Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Voyager Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.